Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Noninvasive monitoring of low-grade prostate cancer with a urinary biomarker test could reduce the need for biopsies and serial imaging, according to a study ...

Scans that makes prostate cancer cells "glow" could cut the need for invasive biopsies, according to new research. The state-of-the-art imaging test could safely halve the number of men who need to ...

Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect.

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...